Lipocine Inc.
Public
LPCN
SectorHealthcare
CountryUnited States
Market cap16.92M
A clinical-stage biopharmaceutical company leveraging proprietary drug delivery technology to develop pharmaceutical products for metabolic and endocrine disorders.
